Thomas Mercher
Impact in
- Genetics top 0.2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
-
- Epigenetics and DNA Methylation 10
- RNA modifications and cancer 9
- Protein Degradation and Inhibitors 5
- Ubiquitin and proteasome pathways 4
- Hematology 26
- Acute Myeloid Leukemia Research 22
- Hematopoietic Stem Cell Transplantation 4
- Co-authors
- D. Gary Gilliland (10 shared papers)Ross L. Levine (6 shared papers)Gerlinde Wernig (6 shared papers)Benjamin H. Lee (5 shared papers)Olivier Bernard (22 shared papers)Rachel Okabe (3 shared papers)Sandra Moore (4 shared papers)Benjamin L. Ebert (2 shared papers)
- Journals
- Blood (12 papers)HemaSphere (3 papers)Blood Advances (2 papers)Leukemia (2 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Thomas Mercher
53 papers receiving 4.1k citations
Thomas Mercher's Hit Papers
Peers
Comparison fields: 5 of 95
- Genetics 2.0k
- Hematology 1.9k
- Rheumatology 620
- Molecular Biology 2.3k
- Immunology 464
Countries citing papers authored by Thomas Mercher
This map shows the geographic impact of Thomas Mercher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Mercher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Mercher more than expected).
Fields of papers citing papers by Thomas Mercher
This network shows the impact of papers produced by Thomas Mercher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Mercher. The network helps show where Thomas Mercher may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Mercher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia Hit paper breakdown → | 2006 | 1071 |
| 2 | 2013 | 403 | |
| 3 | 2006 | 386 | |
| 4 | 2010 | 293 | |
| 5 | 2001 | 195 | |
| 6 | 2001 | 185 | |
| 7 | 2020 | 145 | |
| 8 | 2013 | 124 | |
| 9 | 2012 | 118 | |
| 10 | 2008 | 108 | |
| 11 | 2006 | 91 | |
| 12 | 2007 | 80 | |
| 13 | 2009 | 80 | |
| 14 | 2012 | 77 | |
| 15 | 2005 | 75 | |
| 16 | 2009 | 74 | |
| 17 | 2011 | 64 | |
| 18 | 2009 | 61 | |
| 19 | 2013 | 58 | |
| 20 | 2001 | 48 |
About Thomas Mercher
Thomas Mercher is a scholar working on Molecular Biology, Hematology, Genetics, Pathology and Forensic Medicine and Immunology, having authored 53 papers that have together received 4.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (22 papers), Epigenetics and DNA Methylation (10 papers), RNA modifications and cancer (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Lymphoma Diagnosis and Treatment (7 papers), Protein Degradation and Inhibitors (5 papers), Ubiquitin and proteasome pathways (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). The work is most often cited by research in Genetics (2.0k citations), Hematology (1.9k citations), Rheumatology (620 citations), Molecular Biology (2.3k citations) and Immunology (464 citations). Thomas Mercher has collaborated with scholars based in France, United States and Germany. Frequent co-authors include D. Gary Gilliland, Ross L. Levine, Gerlinde Wernig, Benjamin H. Lee, Olivier Bernard, Rachel Okabe, Sandra Moore, Benjamin L. Ebert, Yana Pikman and Martha Wadleigh. Their work appears in journals such as Blood, HemaSphere, Blood Advances, Leukemia and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.